FDA says Merck’s HIV drug gets generic threat (Reuters)
Reuters – Health regulators said they have received applications from generic drugmakers to make copycat versions of Merck & Co’s HIV drug Isentress, GlaxoSmithKline’s HIV drug Epivir and Bayer AG’s birth control pill Beyaz.
View full post on Yahoo! News: Health News
Leave a Reply